NFE2L2 and Alzheimer disease: These compounds target key genes such as SLC2A1, ESR1, NFE2L2, NFKB1, MAOA, CYP1B1, AKR1B1, MMP9, TTR, CYP19A1, DPP4, HSD17B10, PIK3CA, PIK3CB, XDH, KDR, SRC, TOP2A, and GLO1, which are involved in critical AD‐related processes.